These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Influence of CD40 rs1883832 polymorphism in susceptibility to and clinical manifestations of biopsy-proven giant cell arteritis. Rodríguez-Rodríguez L; Castañeda S; Vázquez-Rodríguez TR; Morado IC; Marí-Alfonso B; Gómez-Vaquero C; Miranda-Filloy JA; Narvaez J; Ortego-Centeno N; Blanco R; Fernández-Gutiérrez B; Martín J; González-Gay MA J Rheumatol; 2010 Oct; 37(10):2076-80. PubMed ID: 20682661 [TBL] [Abstract][Full Text] [Related]
25. Multiple sclerosis associates with LILRA3 deletion in Spanish patients. Ordóñez D; Sánchez AJ; Martínez-Rodríguez JE; Cisneros E; Ramil E; Romo N; Moraru M; Munteis E; López-Botet M; Roquer J; García-Merino A; Vilches C Genes Immun; 2009 Sep; 10(6):579-85. PubMed ID: 19421224 [TBL] [Abstract][Full Text] [Related]
26. Impact of the leucocyte immunoglobulin-like receptor A3 (LILRA3) on susceptibility and subphenotypes of systemic lupus erythematosus and Sjögren's syndrome. Du Y; Su Y; He J; Yang Y; Shi Y; Cui Y; Luo C; Wu X; Liu X; Hu F; Ma X; Zheng L; Zhang J; Zuo X; Sheng Y; Wu L; Zhang X; Guo J; Li Z Ann Rheum Dis; 2015 Nov; 74(11):2070-5. PubMed ID: 24906639 [TBL] [Abstract][Full Text] [Related]
27. Phenotype-haplotype correlation of IRF5 in systemic sclerosis: role of 2 haplotypes in disease severity. Dieude P; Dawidowicz K; Guedj M; Legrain Y; Wipff J; Hachulla E; Diot E; Sibilia J; Mouthon L; Cabane J; Amoura Z; Crakowski JL; Carpentier P; Avouac J; Meyer O; Kahan A; Boileau C; Allanore Y J Rheumatol; 2010 May; 37(5):987-92. PubMed ID: 20231204 [TBL] [Abstract][Full Text] [Related]